NINGBO SANXING MEDICAL ELECTRIC CO.,LTD. Financials Ningbo Sanxing Medical Electric Co.,Ltd.
Equities
601567
CNE100001567
Electrical Components & Equipment
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.86 CNY | -0.91% |
|
-4.49% | +65.17% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 9,221 | 22,615 | 18,980 | 28,947 | 47,783 | - |
| Enterprise Value (EV) 1 | 9,221 | 22,615 | 18,980 | 28,947 | 47,783 | 47,783 |
| P/E ratio | 9.64 x | 32.6 x | 20.1 x | 15.2 x | 21.2 x | 17.4 x |
| Yield | - | - | - | 3.17% | 2.47% | 3.05% |
| Capitalization / Revenue | - | 3.22 x | 2.09 x | 2.53 x | 3.27 x | 2.84 x |
| EV / Revenue | - | 3.22 x | 2.09 x | 2.53 x | 3.27 x | 2.84 x |
| EV / EBITDA | - | 21.2 x | 13.4 x | 11.2 x | 13.9 x | 12.7 x |
| EV / FCF | - | - | - | 21.5 x | 27.4 x | 20.6 x |
| FCF Yield | - | - | - | 4.66% | 3.65% | 4.84% |
| Price to Book | - | 2.55 x | 2 x | 2.63 x | 3.84 x | 3.34 x |
| Nbr of stocks (in thousands) | 13,86,569 | 13,86,569 | 14,07,977 | 14,12,070 | 14,11,197 | - |
| Reference price 2 | 6.650 | 16.31 | 13.48 | 20.50 | 33.86 | 33.86 |
| Announcement Date | 19/04/21 | 25/04/22 | 26/04/23 | 25/04/24 | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 7,023 | 9,098 | 11,463 | 14,591 | 16,843 |
| EBITDA 1 | - | 1,068 | 1,415 | 2,578 | 3,444 | 3,752 |
| EBIT 1 | - | 851.2 | 1,152 | 2,270 | 2,731 | 3,328 |
| Operating Margin | - | 12.12% | 12.67% | 19.81% | 18.72% | 19.76% |
| Earnings before Tax (EBT) 1 | - | 846.8 | 1,152 | 2,262 | 2,732 | 3,329 |
| Net income 1 | 956.1 | 690 | 948.1 | 1,904 | 2,258 | 2,752 |
| Net margin | - | 9.83% | 10.42% | 16.61% | 15.48% | 16.34% |
| EPS 2 | 0.6900 | 0.5000 | 0.6700 | 1.350 | 1.600 | 1.948 |
| Free Cash Flow 1 | - | - | - | 1,348 | 1,745 | 2,314 |
| FCF margin | - | - | - | 11.76% | 11.96% | 13.74% |
| FCF Conversion (EBITDA) | - | - | - | 52.3% | 50.67% | 61.67% |
| FCF Conversion (Net income) | - | - | - | 70.82% | 77.27% | 84.09% |
| Dividend per Share 2 | - | - | - | 0.6500 | 0.8367 | 1.033 |
| Announcement Date | 19/04/21 | 25/04/22 | 26/04/23 | 25/04/24 | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | 1,348 | 1,745 | 2,314 |
| ROE (net income / shareholders' equity) | - | 7.9% | 10.3% | 18.5% | 20% | 20% |
| ROA (Net income/ Total Assets) | - | - | - | - | 10.1% | 11.1% |
| Assets 1 | - | - | - | - | 22,359 | 24,798 |
| Book Value Per Share 2 | - | 6.400 | 6.750 | 7.790 | 8.820 | 10.10 |
| Cash Flow per Share 2 | - | 0.1400 | 0.8700 | 1.350 | 1.980 | 2.190 |
| Capex 1 | - | 294 | 404 | 553 | 450 | 392 |
| Capex / Sales | - | 4.19% | 4.44% | 4.83% | 3.08% | 2.32% |
| Announcement Date | 19/04/21 | 25/04/22 | 26/04/23 | 25/04/24 | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
33.86
CNY
Average target price
35.25
CNY
Spread / Average Target
+4.11%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +65.17% | 6.59B | |
| -4.91% | 3.36B | |
| +20.42% | 3.33B | |
| -11.91% | 2.1B | |
| -24.43% | 1.95B | |
| -1.56% | 1.77B | |
| -16.81% | 1.17B | |
| +6.59% | 1.02B | |
| -18.66% | 906M | |
| -23.52% | 857M |
- Stock Market
- Equities
- 601567 Stock
- Financials Ningbo Sanxing Medical Electric Co.,Ltd.
